On-Demand Learning

Patent

Past 3 Months

Recorded on: Jul. 23, 2013

JOHN WHITE: Now I get to introduce Rebecca and the next topic. But I told you, Ben brings passion to 102(g), and for that reason alone it's a shame that it's gone. Because it's such a fun topic. Our next topic is 103, as seen through the lens of district court, and importantly, CAFC decisions. And the reason we look at 103 from all angles, and indeed all of prior art from all angles, is it matters. The patent office takes one view and the CAFC helps ...

From the program: Prior Art, Obviousness, and the America Invents Act in 2013

Released on: Aug. 5, 2013

Patent reform has arrived: what will be its impact on those touchstones of patentability, prior art and obviousness?  102 was already a complicated concept for patent practitioners, having undergone evolving interpretations in the PTO and CAFC.  How will the AIA now complicate matters further?  What aspects of current 102 understanding carry over to new 102?  How does the concept of “prior art” and circumstance collide in the 21st ...

Released on: Jul. 17, 2013

Taken from the briefing Assoc. for Mol. Path. v. Myriad: Isolated Human DNA is Not Patent-Eligible Subject Matter recorded June, 2013.On June 13, 2013, the U.S. Supreme Court held that naturally occurring, isolated human DNA was not patentable subject matter. The litigation involved Myriad’s patents covering, inter alia, isolated human DNA sequences known as the BRCA1 and BRCA2 genes. Mutations in one of these genes can dramatically increase an individual’s ...

Recorded on: Jul. 2, 2013

MARTA GROSS: All right, welcome back, everyone. And so now we're going to move into the next module of the three modules that we're doing today. As I mentioned to you this morning when I was giving the overview, this is the module where what we're planning on doing is I'm going to give probably a 15 or 20 minute background on what I call patent landscape. Which is going to go into some scenarios where you might have your patent attorney do some analysis ...

From the program: Understanding Patent Law 2013

Released on: Jul. 12, 2013

As the America Invents Act becomes part of current practice of patent law, you may think it is not possible to gain an understanding of this complicated field of law in one day. You would be incorrect. Whether you are new to patent law or are trying to refresh your knowledge of this field, this program will cover the key points you need to get up to speed. In particular, this program will cover all types of patent issues that may arise ...

Recorded on: Sep. 23, 2013

Taken from the Web Program Building a Law Department IP Licensing Program 2013: Driving Shareholder Value Recorded September, 2013 in San FranciscoAntitrust Considerations [00:48:40] Regulatory limitations/impacts Hart Scott Rodino Private “defensive” actions The purchase price of this segment includes the following article(s) from the Course Handbook available online: Presentation Material Antitrust ConsiderationsRichard S. Taffet Antitrust ...

Recorded on: Jul. 2, 2013

MARTA GROSS: OK, welcome back everyone. It's 3:15. And before we get started and I introduce our next panel, I just would like to remind everyone and ask that you fill out the evaluations. We really do look at them. I look at them. Sima looks at them. The panelists look at them. We're interested in hearing what you want to hear more about, the details and all that. Again, this is a lot of subject matter we're trying to cover in one day. And we recognize ...

Recorded on: Jul. 23, 2013

JOHN M. WHITE: Welcome back. It is now the afternoon session. And again, just to be mindful, we're recording and transmitting this around the web. And so we'll stick right to the time schedule. But don't let that interrupt your need to get some coffee, stretch your legs, that sort of thing. But for us, we're recording. So we'll stick to it. And so we begin the afternoon. Now, the afternoon kicks off with a look at old 102(f) and 102(g) and how it ...

Recorded on: Jul. 2, 2013

MARTA: And that's it. I took a smidge longer than I wanted. But I'm going to turn it over to our two panelists. Jane Gunnison is a partner from Ropes and Gray in New York. She's been practicing patent law in the areas I already mentioned in the biotech life sciences space for about 20 years now. And she's had a lot of experience in all different areas of technology and will be bringing that viewpoint. Sitting next to her is Chris Tobin, who's a partner ...

Recorded on: Jul. 23, 2013

JOHN WHITE: All right. With that, I get to introduce our speakers. So our first speaker this morning is Len Svensson. He comes to us from the San Diego office of Birch, Stewart, Kolasch, and Birch. Len has been speaking for PLI for the better part of a decade at this point. He has a degree in biochemistry from University of Maryland and then a law degree from George Mason University. And he came out to California as part of the gold rush, I guess, ...

Recorded on: Jul. 23, 2013

JOHN: Welcome back. It's 11:15. We're back on cameras that work for all those out there in the ether. And welcome back to all those in live attendance as well. Our next segment of the program is fascinating-- not that the others were not fascinating as well. Because it's all very interesting. I feel like a frequent flyer customer. When I'm standing in line with my boarding pass and they say, our preferred customers, please, and I obviously don't go. ...

Recorded on: Jul. 23, 2013

JOHN WHITE: Good afternoon. We are welcoming ourselves back, I'm welcoming you back to the last segment of our program today. We'll run until, I think, five-- BOB SPAR: Do you have questions on there? JOHN WHITE: --30? Yes. And we have some questions. We run until 5 o'clock, I'm sorry. I was too enthusiastic about this, 5:30. But we have some questions. Let me go over some questions we have from those on the web. And I'll try to extend this toward ...